Cytokinetics EVP R&D Malik Fady Ibraham disposes of common shares worth $239,015

Bitget2026/09/22 22:15

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Cytokinetics EVP Research & Development Malik Fady Ibraham exercised stock options for 3,500 shares at USD 7.8 on Sept. 22, 2026.
He sold 3,500 shares the same day at USD 68.29.
Directly held common stock ended unchanged at 153,902 shares.
Non-qualified stock options held fell to 23,386.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000096), on September 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Cytokinetics EVP R&D Malik Fady Ibraham disposes of common shares worth $239,015

You may also like

Crypto prices